title: Lamivudine (3TC)-induced contact dermatitis.
abstract: The nucleoside analogue lamivudine (3TC) is commonly used in multidrug therapy of human immunodeficiency virus-1 disease because it not only potentiates the antiviral effects of other reverse transcriptase inhibitors, but it is also relatively nontoxic. We present a patient who developed a contact dermatitis to lamivudine after prolonged exposure.
authors.affiliation: Department of Dermatology, National Naval Medical Center, Bethesda, Maryland 20889-5600, USA.
authors.forename: K J
authors.initials: KJ
authors.lastname: Smith
authors.forename: R
authors.initials: R
authors.lastname: Buckley
authors.forename: H
authors.initials: H
authors.lastname: Skelton
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine